Benjamin F. Edwards & Company’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7
Closed -$1K 1806
2022
Q1
$1K Sell
7
-30
-81% -$3.96K ﹤0.01% 1695
2021
Q4
$7K Sell
37
-19
-34% -$4.48K ﹤0.01% 1449
2021
Q3
$14K Sell
56
-48
-46% -$13.7K ﹤0.01% 1307
2021
Q2
$43K Sell
104
-21
-17% -$8.32K ﹤0.01% 1061
2021
Q1
$49K Sell
125
-6
-5% -$2.96K ﹤0.01% 1009
2020
Q4
$74K Sell
131
-104
-44% -$65.9K ﹤0.01% 859
2020
Q3
$164K Buy
235
+125
+114% +$97.5K 0.01% 635
2020
Q2
$87K Buy
110
+44
+67% +$33.2K 0.01% 773
2020
Q1
$39K Buy
66
+13
+25% +$12.7K ﹤0.01% 904
2019
Q4
$60K Sell
53
-1
-2% -$1.09K ﹤0.01% 926
2019
Q3
$64K Sell
54
-44
-45% -$67.2K 0.01% 851
2019
Q2
$162K Buy
+98
New +$170K 0.01% 583
2018
Q4
Sell
-7
Closed -$13K 1693
2018
Q3
$13K Buy
7
+1
+17% +$2.07K ﹤0.01% 1212
2018
Q2
$13K Buy
6
+2
+50% +$4.56K ﹤0.01% 1200
2018
Q1
$9K Hold
4
﹤0.01% 1281
2017
Q4
$10K Buy
4
+1
+33% +$2.03K ﹤0.01% 1192
2017
Q3
$6K Hold
3
﹤0.01% 1272
2017
Q2
$5K Buy
+3
New +$3.62K ﹤0.01% 1223
2016
Q2
Sell
-15
Closed -$9K 1081
2016
Q1
$9K Buy
15
+7
+88% +$4.3K ﹤0.01% 818
2015
Q4
$6K Sell
8
-7
-47% -$6.99K ﹤0.01% 932
2015
Q3
$17K Hold
15
﹤0.01% 755
2015
Q2
$34K Hold
15
0.01% 666
2015
Q1
$24K Buy
+15
New +$19.8K 0.01% 720

Other funds holding BLUE

Benjamin F. Edwards & Company's BLUE Position: Q2 2022 in Review

Benjamin F. Edwards & Company sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 7 shares — an estimated $1K sold.

Benjamin F. Edwards & Company first reported a position in BLUE in Q1 2015 and held it in 23 quarters. The position peaked at $164K in Q3 2020. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • Benjamin F. Edwards & Company reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 7 bluebird bio shares in Q2 2022, an estimated $1K.
  • Benjamin F. Edwards & Company first reported a position in bluebird bio in Q1 2015 and held it in 23 quarters.
  • Benjamin F. Edwards & Company's bluebird bio position peaked at $164K in Q3 2020.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2022, filed 12 Aug 2022.